Cargando…

Clinical utilization of anti-vascular endothelial growth-factor agents and patient monitoring in retinal vein occlusion and diabetic macular edema

PURPOSE: To examine the utilization of bevacizumab and ranibizumab and disease monitoring in patients with branch or central retinal vein occlusion (BRVO/CRVO) or diabetic macular edema (DME) in clinical practice. PATIENTS AND METHODS: This retrospective claims analysis included newly diagnosed pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kiss, Szilárd, Liu, Ying, Brown, Joseph, Holekamp, Nancy M, Almony, Arghavan, Campbell, Joanna, Kowalski, Jonathan W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155807/ https://www.ncbi.nlm.nih.gov/pubmed/25210429 http://dx.doi.org/10.2147/OPTH.S60893

Ejemplares similares

Anti-vascular endothelial growth factor agent reduces inflammation in macular edema with central retinal vein occlusion
por: Mashima, Asako, et al.
Publicado: (2019)

Treatment of macular edema due to retinal vein occlusions
por: Channa, Roomasa, et al.
Publicado: (2011)

Vitrectomy for macular edema due to retinal vein occlusion
por: Kumagai, Kazuyuki, et al.
Publicado: (2019)

Role of the choroidal vascularity index in branch retinal vein occlusion (BRVO) with macular edema
por: Hwang, Bo-Een, et al.
Publicado: (2021)

Correlation between vascular endothelial growth factor and nonperfused areas in macular edema secondary to branch retinal vein occlusion
por: Fujikawa, Masato, et al.
Publicado: (2013)

Strategy for the Management of Macular Edema in Retinal Vein Occlusion: The European VitreoRetinal Society Macular Edema Study
por: Adelman, Ron A., et al.
Publicado: (2015)

Efficacy and tolerability of bilateral sustained-release dexamethasone intravitreal implants for the treatment of noninfectious posterior uveitis and macular edema secondary to retinal vein occlusion
por: Ryder, Steven J, et al.
Publicado: (2015)

Cytokines and the Pathogenesis of Macular Edema in Branch Retinal Vein Occlusion
por: Noma, Hidetaka, et al.
Publicado: (2019)

Corrigendum to “Strategy for the Management of Macular Edema in Retinal Vein Occlusion: The European VitreoRetinal Society Macular Edema Study”
por: Adelman, Ron A., et al.
Publicado: (2015)

ASSOCIATION BETWEEN EARLY ANATOMIC RESPONSE TO ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY AND LONG-TERM OUTCOME IN DIABETIC MACULAR EDEMA: An Independent Analysis of Protocol i Study Data
por: Dugel, Pravin U., et al.
Publicado: (2019)

A Meta-Analysis of Anti-Vascular Endothelial Growth Factor Remedy for Macular Edema Secondary to Central Retinal Vein Occlusion
por: Huang, Peirong, et al.
Publicado: (2013)

Visual Function for Driving in Diabetic Macular Edema and Retinal Vein Occlusion Post-Stabilization with Anti-Vascular Endothelial Growth Factor
por: Nixon, Donald R, et al.
Publicado: (2021)

Anti-Vascular Endothelial Growth Factor Therapy with or Without Initial Steroid Therapy for Macular Edema in Branch Retinal Vein Occlusion
por: Noma, Hidetaka, et al.
Publicado: (2023)

Topographic patterns of retinal edema in eyes with branch retinal vein occlusion and their association with macular edema recurrence
por: Park, Hae Min, et al.
Publicado: (2021)

Treatment of Branch Retinal Vein Occlusion induced Macular Edema with Bevacizumab
por: Abegg, Mathias, et al.
Publicado: (2008)

Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion
por: Udaondo, Patricia, et al.
Publicado: (2011)

Arteriovenous Sheathotomy for Persistent Macular Edema in Branch Retinal Vein Occlusion
por: Sohn, Joon Hong, et al.
Publicado: (2006)

Safety and Efficacy of Ranibizumab in Macular Edema following Retinal Vein Occlusion
por: Gallego-Pinazo, Roberto, et al.
Publicado: (2012)

Consecutive Macular Edema and Visual Outcome in Branch Retinal Vein Occlusion
por: Baek, Sung Uk, et al.
Publicado: (2014)

Microaneurysms cause refractory macular edema in branch retinal vein occlusion
por: Tomiyasu, Taneto, et al.
Publicado: (2016)

Intravitreal ziv-aflibercept for macular edema following retinal vein occlusion
por: Paulose, Remya, et al.
Publicado: (2016)

Prevalence of Serous Macular Detachment in Recurrent Macular Edema Secondary to Retinal Vein Occlusion
por: Şekeroğlu, Mehmet Ali, et al.
Publicado: (2022)

Impact of injection therapy on retinal patients with diabetic macular edema or retinal vein occlusion
por: Hall, John
Publicado: (2016)

Impact of injection therapy on retinal patients with diabetic macular edema or retinal vein occlusion
por: Sivaprasad, Sobha, et al.
Publicado: (2016)

Relationship between vascular endothelial growth factor and macular edema in retinal vein branch obstruction
por: Okawada, Hideaki, et al.
Publicado: (2018)

Retinal vein occlusion and macular edema – critical evaluation of the clinical value of ranibizumab
por: Keane, Pearse A, et al.
Publicado: (2011)

Ranibizumab as an adjunct to laser for macular edema secondary to branch retinal vein occlusion
por: Azad, Rajvardhan, et al.
Publicado: (2012)

Use of Intravitreal Triamcinolone in the Treatment of Macular Edema Related to Retinal Vein Occlusion
por: Sharma, Ashish, et al.
Publicado: (2008)

Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion
por: Gutiérrez, Juan Carlos Mesa, et al.
Publicado: (2008)

Role of inflammation in previously untreated macular edema with branch retinal vein occlusion
por: Noma, Hidetaka, et al.
Publicado: (2014)

Association of electroretinogram and morphological findings in central retinal vein occlusion with macular edema
por: Noma, Hidetaka, et al.
Publicado: (2014)

Branch retinal vein occlusion with sectoral cystoid macular edema in toxoplasmic chorioretinitis
por: Hafidi, Zouheir, et al.
Publicado: (2013)

Management of macular edema due to central retinal vein occlusion – The role of aflibercept
por: Rhoades, William, et al.
Publicado: (2017)

Comparison of Ranibizumab and Bevacizumab for Macular Edema Associated with Branch Retinal Vein Occlusion
por: Son, Bo Kwon, et al.
Publicado: (2017)

Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema
por: Choi, Eun Young, et al.
Publicado: (2019)

Lurbinectedin improves macular edema in a case of central retinal vein occlusion()
por: Simona, Filippo, et al.
Publicado: (2022)

Longitudinal Assessment of the Choroidal Vascularity Index in Eyes with Branch Retinal Vein Occlusion-Associated Cystoid Macular Edema
por: Pant, Praruj, et al.
Publicado: (2023)

Predictors of Visual Acuity Outcomes after Anti–Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Central Retinal Vein Occlusion
por: Sen, Piyali, et al.
Publicado: (2021)

Correlation between macular vessel density and number of intravitreal anti-VEGF agents for macular edema associated with branch retinal vein occlusion
por: Tomita, Ryo, et al.
Publicado: (2019)

Conbercept improves macular microcirculation and retinal blood supply in the treatment of nonischemic branch retinal vein occlusion macular edema
por: Huang, Yikeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_idm5k5sutg58olo6aljgrjm9i1